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Despite advances in assisted reproductive technologies, infertility remains a consistent health problem worldwide. Spermiation
is the process through which mature spermatids detach from the supporting Sertoli cells and are released into the tubule lumen.
Spermiation failure leads to lack of mature spermatozoa and, if not occasional, could result into azoospermia, major cause of
male infertility in human population. Spermatids are led through their differentiation into spermatozoa by the apical ectoplasmic
specialization (aES), a testis-specific, actin-based anchoring junction restricted to the Sertoli-spermatid interface. The aES helps
spermatid movement across the seminiferous epithelium, promotes spermatid positioning, and prevents the release of immature
spermatozoa. To accomplish its functions, aES needs to undergo tightly and timely regulated restructuring. Even if components of
aES are partly known, the mechanism/s through which aES is regulated remains still elusive. In this review, we propose a model by
which the small GTPase Rap1 could regulate aES assembly/remodelling.The characterization of key players in the dynamic of aES,
such as Rap1, could open new possibility to develop prognostic, diagnostic, and therapeutic approaches for male patients under
treatment for infertility as well as it could lead to the identification of new target for male contraception.
1. Introduction
Spermatogenesis is a very complex and regulated process dur-
ing which the diploid spermatogonia divide and differentiate
into haploid spermatozoa [1–4].
The correct development of fertile spermatozoa relies
on the peculiar organization of the seminiferous epithe-
lium. The germinal component (spermatogonia, primary
and secondary spermatocytes, round spermatids, and elon-
gating/elongated spermatids) is strictly interconnected with
the somatic component, the Sertoli cells, which sustains
spermatogenesis giving structural support and nourishment
to germ cells [5, 6]. In mouse adult testis, the germ cells
at different stages of differentiation display a unique pattern
of association with Sertoli cells which can be classified into
twelve stages (from I to XII) [1, 2, 4].
During these stages, spermatids undergo massive mor-
phological modifications such as acquisition of cell polarity,
condensation of chromatin, formation of the acrosome and
tail, and production and elimination of the residual body.
Meanwhile the differentiation process takes place, spermatids
migrate across the entire length of the seminiferous epithe-
lium until they reach the luminal edge where mature sperms
are finally released [1, 7]. So, it is clear that germ cells have
to remain anchored to Sertoli cells till the final steps in order
to avoid a premature release as immature spermatids, with
consequence on the male fertility potential (Figure 1).
The integrity of seminiferous epithelium and the func-
tional cell interconnections are maintained through several
junctional devices that take place between both the Sertoli-
Sertoli cells and the Sertoli-germ cells. Besides junction
types present also in other epithelia, like tight junctions [8–
10] and gap junctions [11, 12], the seminiferous epithelium
exhibits testis-unique anchoring junctions, as the ectoplasmic
specialization (ES) [13, 14] and the desmosome-like junction
[15].
The ES between the Sertoli cells is known as basal
ES (bES). At the basal compartment (Figure 1), the bES
coexists with other junctional structures like tight junction,
gap junction, and desmosome-like junction; all together
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Figure 1: A schematic drawing showing the junctions between Sertoli-Sertoli cells and Sertoli-germ cells as discussed in the review. The
drawing illustrates two Sertoli cells embracing germ cells at different stages of differentiation. The Sertoli-Sertoli cell contacts, namely tight
junction, gap junction, basal ectoplasmic specialization and desmosome-like junction, give rise altogether to the blood-testis barrier (BTB).
The BTB divides the seminiferous epithelium into basal and adluminal compartments. In this last, the apical ectoplasmic specialization (aEs)
is established; aEs is the unique type of anchoring junction between Sertoli cell and elongating/elongated spermatids. It undergoes cycles of
assembling/disassembling. At spermiation, it disassembles definitely to allow sperm release.
contribute to create the blood-testis barrier (BTB). The BTB
physically divides the seminiferous epithelium in two com-
partments, that is, a basal compartmentwhere spermatogonia
and spermatocytes reside, and an adluminal compartment
where spermatids differentiate to develop into spermatozoa
(Figure 1) [16, 17]. The establishment of the BTB is funda-
mental for a successful spermatogenesis; its integrity has to
bemaintained throughout the entire spermatogenesis [18, 19].
The BTB provides in fact an immunological barrier to the
developing male germ cells: it sequesters postmeiotic germ
cells from the systemic circulation, thus preventing the pro-
duction by the host of antibodies against spermatid-specific
antigens whose expression is restricted to spermiogenesis
only [20]. The BTB likely functions also as a gatekeeper,
enabling only the passage through the seminiferous epithe-
lium of selected substances/molecules of support to germ
cells. The molecular components and the functions of the
BTB have been extensively reviewed (for excellent reviews,
see [12, 17, 21]); it will be no longer discussed here.
Conversely, this brief review will focus around the apical
ES (aES), restricted to Sertoli-postmeiotic germ cells at the
adluminal compartment. Differently from bES, aES does not
coexist with other junctions: the aES is the only junctional
device that sustains the association between Sertoli and elon-
gating/elongated spermatids (from step 8 of differentiation)
until the early phase of spermiation when it disassembles
(Figure 1) [13, 22–24].
2. Apical Ectoplasmic Specialization
The aES is the best known anchoring junction in the testis.
Several studies have led to a significant improvement of our
knowledge about its molecular architecture and molecular
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components. On the basis of such studies, the aES is emerged
as a peculiar anchoring junction, being formed by structural
components generally found in somatic adherens junctions
(the cadherins/catenins and nectins/afadin complexes), tight
junctions (such as Jam-C molecules), and focal contacts (the
integrin/laminin complex) (Figure 2) [14, 25, 26]. This high
heterogeneity is thought to permit that the aES accomplishes
its multifunctional role in supporting spermiogenesis. In
details, the aES makes the migration possible, concomitantly
with the differentiation of spermatids across the seminif-
erous epithelium. Moreover, the aES could contribute to
positioning elongating spermatids with their heads pointed
towards the basal compartment. It is to notice that aES is
first assembled within the seminiferous epithelium exactly
when spermatids begin to loss their spherical shape to
become a polarized cell (stage 8) [13, 14, 25]. Finally, the
aES maintains spermatids attached to Sertoli cells until
these are differentiated and ready to be released into the
lumen [13, 23, 24]. It follows that aES has to undergo rapid
cycles of assembly and disassembly, concomitantly with the
progression of spermiogenesis, and that at spermiation the
breakage at cell-cell contacts is definitive. The dynamic of
these cycles must be finely and timely regulated. Despite
many efforts, the mechanisms governing the aES remod-
eling during spermiogenesis/spermiation remain however
obscure.
Herein, we address attention on how aES dynamic
could be regulated. In particular, taking into consideration
new experimental evidence provided independently from
more laboratories, we discuss a model of regulation of
aES assembly/disassembly upon the grounds of findings we
obtained from an animal model that we generated appo-
sitely to inactivate the small Ras-like GTPase Rap1 [27].
Importantly, it is to underline that this model provides the
first genetic link between Rap1 defects and male infertil-
ity; the Rap1[S17N] mutation is resulted to be instrumen-
tal in revealing the cAMP-Epac-Rap1/extracellular signal-
regulated pathway that governs the spermatid-Sertoli cell
adhesion at aES. Moreover, it is worth of mention to recall
attention on the fact that the central cell of our model is the
differentiating spermatid. So far, most works about the aES
regulation highlight putativemechanisms operating in Sertoli
cells, relegating spermatids to a role of merely spectators.
However, the “actors” that are involved in cell-to-cell contact
are at least two. Consequently, our model offers a new point
of view to investigate about aES dynamic, that is, to consider
that also germ cells could be actively engaged.
3. Rap1 Regulates aES Dynamic:
Experimental Evidence
Rap1 is a member of the family of Ras-like small G proteins
[28]; accordingly, it switches between an active conformation
bound to the GTP and an inactive one bound to the GDP.The
cycle between the two alternative states is coordinated by the
guanine nucleotide exchange factors (GEFs), the activators
that allow the binding with GTP, and the GTPase activating
proteins (GAPs) that enhance the hydrolysis of bound GTP
thus leading to Rap1 deactivation [29, 30]. Rap1 functions as
a positional signal and organizer of cell architecture; it follows
that this GTPase is placed upstream signalling pathways that
regulate diverse cellular processes, including morphogenesis
[31, 32], cell differentiation [33], cytoskeletal organization
[34], cytokinesis [35], exocytosis/endocytosis [36], synaptic
plasticity [37], and cell-cell adhesion [30]. As to this last
aspect of Rap1 biology, a growing experimental evidence
in the last years has allowed to highlight some aspects of
Rap1 action in controlling integrin-based as well as cadherin-
based junctional systems; in particular, Rap1 has been shown
to regulate the levels of E-cadherin and VE-cadherin at
the plasma membrane of epithelial and endothelial cells,
respectively [38–42].
Rap1 was first detected in the testis in 2000 [43]. It
is expressed by germ cells throughout spermatogenesis; in
spermatids, in particular, it was immunoprecipitated as a
component of the signaling complex formed by the serine-
threonine kinase B-Raf and the molecular adaptor 14-3-3
theta protein [43]. To verify the role of Rap1 in vivo in the pro-
cess of sperm differentiation, we developed a mouse model.
Transgenic mice that express a dominant negative mutant of
Rap1 (iRap1) were generated; to have the expression of the
mutant Rap1 variant selectively only in the postmeiotic germ
cells, iRap1 was put under the control of the haploid-specific
Protamine-1 promoter [27]. The phenotype of the mutant
mice resulted in a derailment of spermiogenesis due to an
anomalous release of immature round spermatids within
the tubule lumen and low sperm counts. These findings
addressed the research to point up towards the search of Rap1-
regulated adhesionmolecules leading to the discovery of VE-
cadherin and of its epithelial cycle stage specific expression
[27].
The high dynamicity of aES renders it as one of the
most flexible cell-cell junctions in mammalian tissue, maybe
comparable to the better characterized adherens junction at
the endothelial cell barrier. This last is known to be a highly
dynamic structure; it maintains the integrity of the endothe-
lium, but it is also involved in the control of permeability,
leukocyte diapedesis and, more generally speaking, vascular
homeostasis [44]. The stabilization of endothelial adherens
junctions relies on the stabilization at the plasma membrane
of the vascular endothelial cadherin (VE-cadherin) through
activation of Rap1 by the cAMP sensor/Rap1-GEF Epac [45].
It is, in fact, widely known that the increase of intracellular
cAMP leads to the formation of circumferential actin bundles
that support cadherins at adherens junctions; this occurs
through Epac-activated Rap1. Similarly, Rap1 is involved
in the formation of E-cadherin-based cell-cell adhesions
in epithelial cells [38, 40, 41]. However, Aivatiadou et al.
[27] found that not only VE-cadherin is expressed in the
testis, but it localizes at aES level, exhibiting a pattern
of expression that follows aES formation and function; it
appears in the adluminal compartment when aESs are being
formed and disappears at spermiation, with the exception of
the intense staining of the soma of Sertoli cells at the basal
compartment. Interestingly, in iRapmutantmice that express
a dominant negative Rap1, VE-cadherin is more loosely
linked to cytoskeleton and partially tyrosine phosphorylated,
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Figure 2: Molecular components at aES level. The picture shows junctional molecules and associated proteins present at aES as discussed
here; attention is particularly devoted to junctional complexes on the spermatid membrane. As suggested in the text, an initial Sertoli-
spermatid contact may be established by nectins engagement, and then VE-cadherin/catenin complexes contribute to the aES stabilization.
In accordance with the literature, the adhesion molecule Jam-C could be involved in spermatid polarization/positioning by recruiting the
Par6/Par3/aPKC/Cdc42 polarity complex.
two conditions known to be related to impairment of cell-
cell adhesions [27, 41]. At last, we remember that the adaptor
proteins 𝛼-, 𝛽-catenins, essential for linking the cadherins to
actin filaments [46], and p120-catenin are expressed in both
Sertoli and germ cells [47]. Similarly, germ cells express also
afadin [48]. Afadin is a scaffold protein containing an actin-
binding and Ras/Rap-binding domain [29, 49] that has been
reported to regulate the cyclical activation/inactivation of
Rap1 andRhoA [50]. In endothelial and epithelial cells, afadin
is involved in Rap1-dependent assembly of cadherins-based
adherens junctions (AJs) [40, 51, 52]. The Rap1-GTP/afadin
complex mediates the recruitment of p120-catenin to the
plasma membrane [51, 52], thus stabilizing VE-cadherin and
protecting it from endocytosis [53].
The iRap1 animal model by Aivatiadou et al. [27] clearly
demonstrated that Rap1 is involved in the regulation of aES
junction dynamic. However, how Rap1 exerts its control and
what are its protein targets have not been yet dissected.
Very likely, testis VE-cadherin is the adhesion receptor
target of Rap1 in spermatids; this, however, does not mean
that VE-cadherin is the only one. Here, we suggest, in
addition to VE-cadherin, another putative candidate, nectin.
Nectins belong to the superfamily of Ca2+-independent
immunoglobulins that comprises at least four members [49];
they are able to form both homophilic and heterophilic
trans-interactions [49]. Nectins have been shown at aESs;
more specifically, nectin-2 on the Sertoli membrane trans-
interacts with nectin-3 on the spermatid membrane [54]. It
has been reported that the nectin-2/nectin-3 complex at aES
is stabilized by afadin that connects the complex to the actin
filaments [54]. Since afadin could connect with both nectin-
based and cadherin-based junctional systems, Rap1 could
represent the central regulatory link between these two aES
structural complexes. Considering that aESs undergo cycles
of assembly and disassembly and that Rap1 mediates both
the de novo formation and the reestablishment of adherens
junctions [38, 55], the following hypothesis for future experi-
mental research could be suggested.That is, at the assembling,
nectins are first engaged at aES recruiting afadin that, on
its own, is involved in activation of Rap1; this leads to an
accumulation of VE-cadherin at the plasma membrane with
the result of strengthening of the junction. The nectins/VE-
cadherin adhesion molecules have already been described to
be able to connect physically and functionally in endothelial
cell systems [56, 57].
4. Rap1 as an Organizer of
Spermatid Polarization at aES
Rap1 action is accomplished through the cooperation of
different signaling pathways involving several effectors [32,
58, 59]. In its central role of positional signal and organizer
of cell architecture, Rap1 governs the reorganization of actin
cytoskeleton [34, 60, 61]. The great plasticity of the aES
requires a rapid rearrangement of actin cytoskeleton; it is
not surprising if Rap1 could emerge as a regulator of this
cytoskeleton at aES. CDC42 is another Ras-like small GTPase
that belongs to the family of Rho-GTPases [62–64], and
CDC42 is a Rap1 effector. In epithelial as well as endothelial
cells, Epac-activated Rap1 induces CDC42 activation; this
leads to a reorganization of actin cytoskeleton resulting in the
formation of circumferential actin bundles and consequently
in the stability of E-cadherin/VE-cadherin-based cell-cell
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Figure 3: The proposed model of regulation of aES dynamic. The aES structuring/restructuring is governed by a coordinated crosstalk
between Ras-like small GTPases, among which Rap1 is the central core. Under conditions that favor Sertoli-spermatid contacts (TGF𝛽 is
here suggested as one of the putative candidates that promotes the cAMP signaling for establishment of cell-cell contact), the triggered cAMP
elevation leads to Epac-mediated Rap1 activation; Rap1 action stabilizes aES junctions acting on both nectin/afadin and VE-cadherin/catenin
complexes as well as on CDC42 thus promoting actin filament organization. Moreover, activated Rap1 acts on another Rap1 effector, namely,
RA-RhoGAP, so that the activity of Rho-GTPase is switched off.Conversely, under conditions that promote aESdestabilization (here suggested
as a short exposition to TGF𝛽), the consequent decrease in cAMP level leads to Rap1 deactivation with the downstream effects on the junction
stability and F-actin organization; concomitantly, RA-RhoGAP is not activated and the Rho-driven disassembling of aES could take place.
All the proteins discussed here are known to be expressed in male germ cells. See text for details and further discussion.
adhesions [34, 45, 60]. Since CDC42 is expressed in differ-
entiating spermatids [65, 66], it is possible to speculate that
Rap1-mediated CDC42 activation is one of the mechanisms
that stabilize cell-cell contacts at aESs. Not only, but CDC42
may be the Rap1 effector through which Rap1, acting as a
critical regulator of cell polarization [67], controls spermatid
polarization, an event for which the contribution of aES has
been evoked more times, in the seminiferous epithelium.
Cdc42, in fact, is known to work in epithelial cells in concert
with the Par-based polarity protein complex to establish
the apicobasal cell polarity [68, 69]. Interestingly, in sper-
matids the Par6/Cdc42/aPKC complex has been shown to be
recruited to the plasma membrane by Jam-C, a junctional
adhesion molecule found at aES level [65, 70]; Gliki et al.
[65] attributed to Jam-C the role of assembling the cell
polarity complex and, consequently, of promoting spermatid
polarization. However, the pathway though which Jam-C
could fulfill such functions was not dissected. In endothelial
cells, Jam-C regulates vascular endothelial permeability by
modulating VE-cadherin-mediated cell-cell contacts [71]. In
particular, the loss of Jam-C expression by Jam-C knockdown
results in stabilization of VE-cadherin-mediated adhesion
in a Rap1-dependent manner. It follows that the question
of Jam-C and Par6/Cdc42/aPKC complex in differentiating
spermatids deserves a deeper investigation. Again, Rap1
may emerge as the central regulator that supervises both
aES assembly/disassembly and spermatid polarity in a new
system, the spermatid-Sertoli cell adhesion system. In this
regard, it is to notice that just the VE-cadherin-based AJs
have been reported to be essential to establish cell polarity;
here, it is in fact recruited the Rap1-activated cell polar-
ity complex in endothelia [72]. So, it is not to exclude
that Rap1 could mediate spermatid polarization not only
through the Jam-C/polarity complex but also through the
VE-cadherin/polarity complex system.
5. Rap1, Rho, and the Disassembling of aES
Rho belongs, as CDC42 and Rac1, to the family of Rho
GTPases and is involved in the dynamics of F-actin structures
thus influencing cell shape and assembly of AJs. The best
characterized Rho isoforms are RhoA, RhoB, and RhoC
[73, 74]; RhoA and RhoB have been reported in testis and
spermatozoa [66]. While CDC42 and Rac1 are known to act
as Rap1 effectors, that is, downstream the activated Rap1, Rho
GTPase is best known to counteract the action of Rap1 [27,
34, 75]. For example, activation of the Rho GTPase pathway
determines endothelial cell hyperpermeability and could
lead to endothelial barrier disruption [75, 76]. Accordingly,
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overexpression of a constitutively active mutant of Rap1
results in activation of Rac1 and, intriguingly, inactivation
of RhoA [50]. As already noticed, with few exceptions,
members of the Ras-like GTPase super-family cycle, between
an active and inactive state. The continuous cycling between
the two states is tightly controlled by a number of regulatory
proteins that specify where and for how long the signal is
“on” and which cellular function is modulated. In the case
of cell adhesion, for each cellular process triggered by cell-
cell contacts, multiple GTPases must be dynamically turned
“on” or “off” [34, 50, 75]. This “turning” is facilitated by
GEFs and GAPs, respectively. So far, several GEFs and GAPs
have been described tomodulate the organization, molecular
composition, and function of adhesive complexes in different
cell types. In endothelial cells, the second messenger cAMP
induces barrier protective responses against thrombin or
inflammatory mediators [77, 78]. The Rap1 GEFs that are
sensors of cAMP elevation are known as Epac (exchange
protein activated by cAMP), of which there are two variants,
Epac1 and Epac2 [79–81]. Rap1, however, could be activated
also by other GEFs, such as C3G, PDZ-GEFs, and CalDAGs
[59, 82, 83]. Still referring to the endothelial cell AJs, Birukova
et al. [75] have shown that the Rap1 PDZ-GEF cooperates
with Epac to maintain junction integrity; more specifically,
the PDZ-GEF is involved mainly in Rap1 activation under
resting conditions [45], while Epac/s is/are necessary to
further tighten cell-cell contacts [45]. Both Epac1 and Epac2
have been found in mouse testis and male germ cells [80,
84]. Similar to the GEFs, there are various Rap-GAPs that
are specifically targeted to different molecular complexes at
various cellular locations [59]. These GAPs may reverse the
dynamic processes controlled by activated Rap1. Among the
best characterized Rap1-GAPs, there are Rap1-GAP1,2, Spa-
1, and SPAR1,2,3 [59]; so far, however, experimental evidence
for Rap1-GAPs in the testis is still lacking.
This is not the case, on the contrary, for RhoGAPs.
Aivatiadou et al. [80] reported that male germ cells express
RA-RhoGAP. RA-RhoGAP is a RhoGAP that possesses a RA
domain through which it binds to Epac-activated Rap1 thus
acting as a Rap1 effector and transductor of signal from Rap1
to Rho [85]. Indeed, Aivatiadou et al. [80] showed also that
in isolated spermatogenic cells, after stimulation with 8-CPT
(a membrane-permeable analogue of cAMP), Epac-activated
Rap1 colocalizes with RA-RhoGAP. It follows that male germ
cells have the equipment of signaling molecules, including
activators and effectors, through which activated Rap1 could
suppress the action of Rho.
At this point, if Rap1 and Rho are likely the Ras-
like GTPases that govern aES dynamic, a key question
concerns the signal/s responsible for the Rap1/Rho activa-
tion/deactivation at aES. Before the conclusion of this brief
review, we want to provide a further suggestion towards the
direction for this putative signaling molecule. Transform-
ing growth factor-𝛽1 (TGF-𝛽1) functions in diverse cellular
processes, such as tissue differentiation and cell migration.
Recent experimental evidence on signaling that governs
monocyte adhesion and chemotaxis [86] has revealed that
TGF-𝛽1 triggers cAMP elevation leading to Rap1 activation
via Epac; not only this, but also this Rap1 activation, on its
own, results in Rho inactivation through the Rap1-dependent
RhoGAP. In other words, prolonged TGF-𝛽1-treated cells
produce cAMP, which activates sequentially Epac, Rap1, and
Rap1-dependent RhoGAP, resulting in suppression of Rho
and macrophage migration. TGF-𝛽1 is produced in the testis
by both germ cells and Sertoli cells [87]. TGF-𝛽1 may thus
result to be crucial for the restructuring of aES.
Conclusively, here we provide a model (Figure 3) for the
mechanism/s by which Rap1 could potentially regulate aES
dynamic. It is to remark that here we took into consideration
deliberately only spermatids, that is, the cells so far rather
neglected under this context. Restructuring of aES junction
is thought to be dependent on a highly coordinated net-
work of mechanisms of activation/deactivation of Ras-like
GTPases that has Rap1 as its central hub and the Rho-family
GTPases as downstream Rap1-effectors/antagonists. Rap1
action results in the assembly/stabilization/reestablishment
of aES junctions whereas Rho drives their disassembling;
interestingly, the functional Rap1/Rho interaction is proposed
to be vice-versa reciprocal. Obviously, some aspects of the
suggested regulation of aES dynamic need to be verified and
are waiting for the experimental validation.
6. Conclusion
Male infertility is one of the health problems worldwide.
Several defects responsible formale infertility are still unclear,
mostly due to our poor understanding of molecular mech-
anisms that regulate sperm production and release from
the testis, the maturation and transit of the sperm through
the male and female tracts, and the events essential for
fertilization. Because we do not understand entirely these
molecular processes, we cannot diagnose correctly the causes
of male infertility. Upon the grounds of the phenotype that
characterizes the unique animal model developed so far to
investigate in vivo about the nature of the signaling involved
in the regulation of spermatid-Sertoli cell junctions [27],
here we propose two interconnected mechanisms that could
unravel the question of the regulation of a highly dynamic
and essential junction like the aES is.
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